Archived
This content is available here strictly for research, reference, and/or recordkeeping and as such it may not be fully accessible. If you work or study at University of Kentucky and would like to request an accessible version, please use the SensusAccess Document Converter.
Abstract
Coronavirus disease 2019 (COVID-19) is currently a significant cause of acute respiratory failure worldwide, leading to irreversible fibrotic lung disease. In patients with persistent respiratory failure after acute COVID-19 infection, lung transplant is an emerging option. Here, we have presented a case where the patient required venovenous extracorporeal membrane oxygenation (VV-ECMO) support for 33 days until a bilateral lung transplant was performed on day 71 after the initial COVID-19 infection. The early outcomes have been favorable. Currently, no guidelines exist for an acceptable time period after initial COVID-19 infection, duration of negative COVID polymerase chain reaction (PCR) testing, or negative Vero cell culture in the setting of persistent positive COVID PCR testing before listing for a lung transplant. Due to a lack of standardized guidelines, this patient was not listed for a lung transplant until the COVID-19 PCRs came negative on days 47 and 49 after the infection.
Document Type
Article
Publication Date
8-13-2021
Digital Object Identifier (DOI)
https://doi.org/10.7759/cureus.17152
Repository Citation
Sajid, Fatima; Ahmed, Taha; Baz, Maher A.; and Anstead, Michael I., "Lung Transplantation in a Patient with COVID-19-Associated Acute Respiratory Failure" (2021). Internal Medicine Faculty Publications. 277.
https://uknowledge.uky.edu/internalmedicine_facpub/277
Notes/Citation Information
Published in Cureus, v. 13, issue 8, e17152.
Copyright © 2021, Sajid et al.
This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.